Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H WEXLER

Showing results (101-110 of 175) with videos related to

Pageof 18
Sort By:
Journal of Pediatric Hematology/Oncology|March 7, 2003
Effects of therapy on dentofacial development in long-term survivors of head and neck rhabdomyosarcoma: the memorial sloan-kettering cancer center experienceCherry L Estilo, Joseph M Huryn, Dennis H Kraus, et al.
Human Pathology|August 19, 1999
Neuroectodermal differentiation in Ewing's sarcoma family of tumors does not predict tumor behaviorD M Parham, Y Hijazi, S M Steinberg, et al.
Cancer|December 26, 2001
Insulin-like growth factor type 1 (IGF-1) and IGF binding protein-3 in patients with Ewing sarcoma family of tumorsJ A Toretsky, S M Steinberg, M Thakar, et al.
Cancer|December 18, 2008
Phase 1 and pharmacokinetic study of concurrent carboplatin and irinotecan in subjects aged 1 to 21 years with refractory solid tumorsAdam S Levy, Paul A Meyers, Leonard H Wexler, et al.
Pediatric Blood & Cancer|July 29, 2009
Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experienceDenise A Casey, Leonard H Wexler, Melinda S Merchant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Randomized trial of recombinant human granulocyte-macrophage colony-stimulating factor in pediatric patients receiving intensive myelosuppressive chemotherapyL H Wexler, L Weaver-McClure, S M Steinberg, et al.
Pediatric Blood & Cancer|October 21, 2014
Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy (IMRT)Dana L Casey, Danielle N Friedman, Chaya S Moskowitz, et al.
Journal of Pediatric Surgery|November 30, 2016
Paratesticular rhabdomyosarcoma: Importance of initial therapyWilliam J Hammond, Benjamin A Farber, Anita P Price, et al.
Journal of Pediatric Surgery|January 18, 2006
Computed tomographic scan of the chest underestimates the number of metastatic lesions in osteosarcomaMark L Kayton, Andrew G Huvos, Jennifer Casher, et al.
JCO Precision Oncology|June 14, 2023
Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk StratificationHenry de Traux de Wardin, Bin Xu, Josephine K Dermawan, et al.
Pageof 18

Showing results (101-110 of 175) with videos related to

Sort By:
Pageof 18
Journal of Pediatric Hematology/Oncology|March 7, 2003
Effects of therapy on dentofacial development in long-term survivors of head and neck rhabdomyosarcoma: the memorial sloan-kettering cancer center experienceCherry L Estilo, Joseph M Huryn, Dennis H Kraus, et al.
Human Pathology|August 19, 1999
Neuroectodermal differentiation in Ewing's sarcoma family of tumors does not predict tumor behaviorD M Parham, Y Hijazi, S M Steinberg, et al.
Cancer|December 26, 2001
Insulin-like growth factor type 1 (IGF-1) and IGF binding protein-3 in patients with Ewing sarcoma family of tumorsJ A Toretsky, S M Steinberg, M Thakar, et al.
Cancer|December 18, 2008
Phase 1 and pharmacokinetic study of concurrent carboplatin and irinotecan in subjects aged 1 to 21 years with refractory solid tumorsAdam S Levy, Paul A Meyers, Leonard H Wexler, et al.
Pediatric Blood & Cancer|July 29, 2009
Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experienceDenise A Casey, Leonard H Wexler, Melinda S Merchant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
Randomized trial of recombinant human granulocyte-macrophage colony-stimulating factor in pediatric patients receiving intensive myelosuppressive chemotherapyL H Wexler, L Weaver-McClure, S M Steinberg, et al.
Pediatric Blood & Cancer|October 21, 2014
Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy (IMRT)Dana L Casey, Danielle N Friedman, Chaya S Moskowitz, et al.
Journal of Pediatric Surgery|November 30, 2016
Paratesticular rhabdomyosarcoma: Importance of initial therapyWilliam J Hammond, Benjamin A Farber, Anita P Price, et al.
Journal of Pediatric Surgery|January 18, 2006
Computed tomographic scan of the chest underestimates the number of metastatic lesions in osteosarcomaMark L Kayton, Andrew G Huvos, Jennifer Casher, et al.
JCO Precision Oncology|June 14, 2023
Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk StratificationHenry de Traux de Wardin, Bin Xu, Josephine K Dermawan, et al.
Pageof 18